BioXcel Therapeutics director Susan E. Atkins files initial beneficial ownership statement
BTAI•Initial Form 3 filing
BioXcel Therapeutics director Susan E. Atkins filed an initial Form 3 insider ownership statement dated Aug. 12, 2026.
Related News
Speculators turn net long on yen for first time since February
FXY•
Oracle Says Larry Ellison Cancels 10b5-1 Plan To Sell Oracle Stock
ORCL•
Alignment Healthcare CEO John E. Kao reports disposal of common shares worth $7.12 million
ALHC•
Hyperscale Data Executive Chairman Milton C. Ault III buys USD 5,252 of common shares
GPUS•
Nasdaq Trade Halt IPDN Halt News Pending at 07:50 PM
IPDN•